Cargando…

Case Report: Anlotinib Reverses Nivolumab Resistance in Advanced Primary Pulmonary Lymphoepithelioma-Like Carcinoma With FGFR3 Gene Amplification

BACKGROUND: Primary pulmonary lymphoepithelioma-like carcinoma (LELC) is a rare type of non-small cell lung cancer (NSCLC). Currently, anti-programmed death-1 (PD-1)/programmed death ligand-1 (PD-L1) has become an important treatment for NSCLC. Anti-human PD-1 monoclonal antibodies, such as nivoluma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yanyang, Long, Lang, Liu, Jiewei, Zhu, Lingling, Luo, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531585/ https://www.ncbi.nlm.nih.gov/pubmed/34692530 http://dx.doi.org/10.3389/fonc.2021.749682

Ejemplares similares

Comparison of Immunotherapy, Chemotherapy, and Chemoimmunotherapy in Advanced Pulmonary Lymphoepithelioma-Like Carcinoma： A Retrospective Study
por: Xiao, Yi, et al.
Publicado: (2022)

Lymphoepithelioma-like Carcinoma (LELC) of the Prostate
por: Eisa, Waleed, et al.
Publicado: (2016)

Primary Pulmonary Lymphoepithelioma-Like Carcinoma Response Favorably To Nivolumab: A Case Report
por: Qiu, Zhi-Xin, et al.
Publicado: (2019)

Case Report: Primary lymphoepithelioma-like intrahepatic cholangiocarcinoma
por: Liu, Fei, et al.
Publicado: (2023)

A computed tomography-based preoperative risk scoring system to distinguish lymphoepithelioma-like gastric carcinoma from non-lymphoepithelioma-like gastric carcinoma
por: Li, Liming, et al.
Publicado: (2022)

About a case of lymphoepithelioma-like carcinoma of the bladder
por: Chaker, Kays, et al.
Publicado: (2018)

Immune Checkpoint Blockade Therapy May Be a Feasible Option for Primary Pulmonary Lymphoepithelioma-like Carcinoma
por: Wu, Zuohong, et al.
Publicado: (2021)

Combined NK-CIK and PD-1 inhibitor (nivolumab), an effective immunotherapy for treating intrahepatic lymphoepithelioma-like cholangiocarcinoma unassociated with EBV infection: Two case reports and a literature review
por: Sam Saji, Alen, et al.
Publicado: (2023)

Case Report: Advanced pulmonary sarcomatoid carcinoma with adrenal gland metastasis after sintilimab combined with anlotinib treatment
por: Dai, Gangyi, et al.
Publicado: (2023)

Anti-angiogenic therapy for advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective multicenter study
por: Bao, Hejing, et al.
Publicado: (2022)

Prognostic Significance of Regional/Systemic Metabolic Parameters on (18)F-FDG PET in Pulmonary Lymphoepithelioma-Like Carcinoma
por: Li, Yongjiang, et al.
Publicado: (2021)

Pulmonary Lymphoepithelioma-Like Carcinoma: A Mini-Review
por: Hu, Yan, et al.
Publicado: (2020)

Plasma Epstein-Barr Virus-Deoxyribonucleic Acid Copy Number Predicts Disease Progression in Stage I–III Pulmonary Lymphoepithelioma-Like Carcinoma
por: Li, Qi-Wen, et al.
Publicado: (2020)

Unusual presentation of pulmonary lymphoepithelioma‐like carcinoma
por: Oi, Ryoko, et al.
Publicado: (2016)

Primary pulmonary lymphoepithelioma-like carcinoma in Singapore
por: Tay, Chee Kiang, et al.
Publicado: (2018)

Clinical observation of pulmonary lymphoepithelioma-like carcinoma
por: Sha, Zhou, et al.
Publicado: (2021)

Case Report: Anlotinib Combined With Sintilimab as Third-Line Treatment in a Metastatic Urothelial Bladder Carcinoma Patient With FGFR3 Mutation
por: Cao, Jian-zhou, et al.
Publicado: (2021)

Clinicopathological characteristics and cancer-specific prognosis of primary pulmonary lymphoepithelioma-like carcinoma: a population study of the US SEER database and a Chinese hospital
por: Zhang, Qun, et al.
Publicado: (2023)

Tocilizumab (monoclonal anti-IL-6R antibody) reverses anlotinib resistance in osteosarcoma
por: Xu, Jiuhui, et al.
Publicado: (2023)

Outcomes of Anlotinib Maintenance Therapy in Patients With Advanced NSCLC in a Real-World Setting
por: Li, Jia, et al.
Publicado: (2022)

Efficacy and safety of anlotinib plus programmed death-1 blockade versus anlotinib monotherapy as second or further-line treatment in advanced esophageal squamous cell carcinoma: A retrospective study
por: Liu, Ying, et al.
Publicado: (2022)

Dramatic Response of Pulmonary Sarcomatoid Carcinoma to Nivolumab Combined with Anlotinib: A Case Report
por: Jin, Caibao, et al.
Publicado: (2020)

Anlotinib combined with pembrolizumab as first-line treatment for advanced pulmonary sarcomatoid carcinoma: a case report and literature review
por: Wen, Yingmei, et al.
Publicado: (2023)

Gemcitabine Plus Anlotinib Is Effective and Safe Compared to Gemcitabine Plus Docetaxel in Advanced Soft Tissue Sarcoma
por: Liu, Zhiyong, et al.
Publicado: (2022)

Lymphoepithelioma-Like Carcinoma of the Colon
por: Mori, Yasuharu, et al.
Publicado: (2013)

Lymphoepithelioma-like carcinoma of the breast
por: Nankin, Nils L., et al.
Publicado: (2015)

Lymphoepithelioma-like carcinoma of the skin
por: Oliveira, Cristiano Claudino, et al.
Publicado: (2018)

Molecular and Clinical Characteristics of Primary Pulmonary Lymphoepithelioma-Like Carcinoma
por: Fan, Ying, et al.
Publicado: (2021)

The clinical analysis of pulmonary lymphoepithelioma-like carcinoma with epithelioid granuloma
por: Gao, Guoying, et al.
Publicado: (2020)

Anlotinib Downregulates RGC32 Which Provoked by Bevacizumab
por: Liu, Zhujun, et al.
Publicado: (2022)

Case Report: Partial Response Following Nivolumab Plus Docetaxel in a Patient With EGFR Exon 20 Deletion/Insertion (p.N771delinsGF) Mutant Lung Adenocarcinoma Transdifferentiated From Squamous Cell Carcinoma
por: Zhu, Lingling, et al.
Publicado: (2022)

Association between anlotinib trough plasma concentration and treatment outcomes in advanced non-small-cell lung cancer
por: Chen, Ling, et al.
Publicado: (2023)

The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma
por: Hong, Shaodong, et al.
Publicado: (2019)

A Case of Primary Pulmonary Lymphoepithelioma-like Carcinoma Misdiagnosed as Adenocarcinoma
por: Jeong, Jae Seok, et al.
Publicado: (2013)

Primary pulmonary lymphoepithelioma-like carcinoma combined with situs inversus totalis
por: Zhu, Tao, et al.
Publicado: (2019)

Case Report: Long-term remission of malignant pleural and peritoneal effusion in a case of advanced lung adenocarcinoma treated with combined crizotinib and anlotinib therapy
por: Tian, Jin, et al.
Publicado: (2023)

Gemcitabine-capecitabine: a therapeutic option in previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma
por: Pons-Tostivint, Elvire
Publicado: (2023)

Lymphoepithelioma-like Carcinoma of the Urinary Bladder
por: Yun, Han Ki, et al.
Publicado: (2010)

Lymphoepithelioma-like carcinoma of the uterine cervix
por: Yun, Hyun Sil, et al.
Publicado: (2017)

Checkpoint Inhibition in the Treatment of Unresectable, Advanced Lymphoepithelioma-like Hepatocellular Carcinoma
por: Hermel, David J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1vpt0g90clrl3dom1mfgd8o027